This report studies the global market size of Neuromodulation Devices and Implantable Infusion Pumps in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neuromodulation Devices and Implantable Infusion Pumps in these regions. This research report categorizes the global Neuromodulation Devices and Implantable Infusion Pumps market by top players/brands, region, type and end user. This report also studies the global Neuromodulation Devices and Implantable Infusion Pumps market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position. The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015. USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units? implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment. With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015. It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy. The global Neuromodulation Devices and Implantable Infusion Pumps market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Neuromodulation Devices and Implantable Infusion Pumps market based on company, product type, end user and key regions. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Medtronic Boston Scientific Corporation St. Jude Medical Synapse Biomedical Nevro Corporation Neuropace Cyberonics Autonomic Technologies Avery Biomedical Greatbatch Medical Market size by Product Spinal Cord Stimulation Deep Brain Stimulation Sacral Nerve Stimulation Vagal Nerve Stimulation Gastric Stimulation Transcranial magnetic Stimulation Transcutaneous Electrical Stimulation Other Market size by End User Parkinson's disease Epilepsy Pain Other Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Neuromodulation Devices and Implantable Infusion Pumps market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025. To understand the structure of Neuromodulation Devices and Implantable Infusion Pumps market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Neuromodulation Devices and Implantable Infusion Pumps companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Neuromodulation Devices and Implantable Infusion Pumps submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Neuromodulation Devices and Implantable Infusion Pumps are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neuromodulation Devices and Implantable Infusion Pumps market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Neuromodulation Devices and Implantable Infusion Pumps Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Product 1.4.2 Spinal Cord Stimulation 1.4.3 Deep Brain Stimulation 1.4.4 S
